Short Interest in Straumann Holding AG (OTCMKTS:SAUHY) Decreases By 80.1%

Posted by Tyrone Williams on Dec 25th, 2025

Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) saw a large decrease in short interest during the month of December. As of December 15th, there was short interest totaling 3,073 shares, a decrease of 80.1% from the November 30th total of 15,433 shares. Based on an average daily trading volume, of 282,575 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the company’s stock are short sold. Currently, 0.0% of the company’s stock are short sold. Based on an average daily trading volume, of 282,575 shares, the short-interest ratio is currently 0.0 days.

Straumann Stock Performance

OTCMKTS SAUHY opened at $11.70 on Thursday. The firm has a 50-day moving average of $11.79 and a 200-day moving average of $12.07. Straumann has a 52-week low of $10.30 and a 52-week high of $15.07.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on SAUHY. UBS Group upgraded Straumann from a “sell” rating to a “neutral” rating in a report on Tuesday, November 4th. Deutsche Bank Aktiengesellschaft raised Straumann from a “hold” rating to a “buy” rating in a research report on Friday, October 31st. Morgan Stanley reissued an “underweight” rating on shares of Straumann in a report on Monday, December 15th. The Goldman Sachs Group cut shares of Straumann from a “strong-buy” rating to a “neutral” rating in a research note on Monday, October 13th. Finally, Citigroup reaffirmed a “sell” rating on shares of Straumann in a research report on Wednesday, October 22nd. Two research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, Straumann has an average rating of “Hold”.

Read Our Latest Stock Analysis on SAUHY

Straumann Company Profile

(Get Free Report)

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.